Venus Remedies Limited

Company Profile

Venus Remedies Limited had its IPO on under the ticker symbol 526953.

The company operates in the Other sector and Other industry. Venus Remedies Limited has a staff strength of 0 employees.

Stock update

Shares of Venus Remedies Limited opened at ₹234 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹230.3 - ₹234.8, and closed at ₹230.85.

This is a -0.86% slip from the previous day's closing price.

A total volume of 2,790 shares were traded at the close of the day’s session.

In the last one week, shares of Venus Remedies Limited have increased by +0.81%.

Venus Remedies Limited's Key Ratios

Venus Remedies Limited has a market cap of ₹1.06 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Venus Remedies Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Venus Remedies Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Venus Remedies Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Venus Remedies Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Venus Remedies Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Venus Remedies Limited’s profitability.

Venus Remedies Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Venus Remedies Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹6.01 billion

Total Liabilities

₹825.70 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Venus Remedies Limited ended 2024 with ₹6.01 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹6.01 billion while shareholder equity stood at ₹4.60 billion.

Venus Remedies Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹825.70 million in other current liabilities, 133670000.00 in common stock, ₹4.47 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹325.04 million and cash and short-term investments were ₹749.15 million. The company’s total short-term debt was ₹36,142,000 while long-term debt stood at ₹386.79 million.

Venus Remedies Limited’s total current assets stands at ₹3.23 billion while long-term investments were ₹0 and short-term investments were ₹211.99 million. Its net receivables were ₹766.60 million compared to accounts payable of ₹508.40 million and inventory worth ₹1.20 billion.

In 2024, Venus Remedies Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Venus Remedies Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹230.85

52-Week High

₹301.8

52-Week Low

₹145

Analyst Target Price

₹

Venus Remedies Limited stock is currently trading at ₹230.85 per share. It touched a 52-week high of ₹301.8 and a 52-week low of ₹301.8. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹257.61 and 200-day moving average was ₹205.57 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.